Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database

[1]  R. Gutzmer,et al.  Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanoma , 2011, International journal of cancer.

[2]  M. Kashani-Sabet,et al.  Selective Sentinel Lymph Node Dissection for Melanoma: Importance of Harvesting Nodes with Lower Radioactive Counts without the Need for Blue Dye , 2011, Annals of Surgical Oncology.

[3]  J. Kirkwood,et al.  Prognostic significance of autoimmunity during treatment of melanoma with interferon , 2006, Seminars in Immunopathology.

[4]  J. Barrett,et al.  Melanoma sentinel node biopsy and prediction models for relapse and overall survival , 2010, British Journal of Cancer.

[5]  C. Corless,et al.  Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. , 2010, American journal of surgery.

[6]  P. G. Lang,et al.  Lymphatic Invasion Identified by Monoclonal Antibody D2-40, Younger Age, and Ulceration: Predictors of Sentinel Lymph Node Involvement in Primary Cutaneous Melanoma , 2009 .

[7]  J. Lang.  The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center , 2009 .

[8]  L. Schmidt-Thieme,et al.  Identifying Patients at Risk , 2009 .

[9]  S. Mocellin,et al.  Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI) , 2009, Annals of Surgical Oncology.

[10]  S. Ariyan,et al.  Effect of multiple-nodal basin drainage on cutaneous melanoma. , 2008, Archives of surgery.

[11]  D. Roulin,et al.  Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  L. French,et al.  The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma – a retrospective analysis of 392 cases , 2008, British Journal of Cancer.

[13]  C. Kaur,et al.  The correlation of regression in primary melanoma with sentinel lymph node status , 2007, Journal of Clinical Pathology.

[14]  Katherine S Panageas,et al.  Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  V. Sondak,et al.  The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma , 2007, Cancer.

[16]  K. Busam,et al.  Primary Cutaneous Melanoma with Regression Does not Require a Lower Threshold for Sentinel Lymph Node Biopsy , 2007, Annals of Surgical Oncology.

[17]  S. O’Day,et al.  Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma. , 2006, The Journal of investigative dermatology.

[18]  D. Elder,et al.  Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma , 2006, Cancer.

[19]  N. Cascinelli,et al.  Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Jennifer L. Schwartz,et al.  Significance of Multiple Lymphatic Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy , 2006, Annals of Surgical Oncology.

[21]  K. Heine Stokholm,et al.  Sentinel node biopsy in cutaneous melanoma , 2006, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[22]  D. Reintgen,et al.  Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes , 1998, Annals of Surgical Oncology.

[23]  J. Homsi,et al.  Cutaneous melanoma: prognostic factors. , 2005, Cancer control : journal of the Moffitt Cancer Center.

[24]  David Elder,et al.  Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Claus Garbe,et al.  Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Stromberg,et al.  Correlation Between Prognostic Factors and Increasing Age in Melanoma , 2004, Annals of Surgical Oncology.

[27]  H. Shaw,et al.  Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy? , 2004, Annals of Surgical Oncology.

[28]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[29]  I. Jacobs,et al.  Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy. , 2003, Journal of the American Academy of Dermatology.

[30]  Jeffrey E. Lee,et al.  Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients , 2003, Annals of Surgical Oncology.

[31]  S. Leong.  Selective sentinel lymphadenectomy for malignant melanoma. , 2003, The Surgical clinics of North America.

[32]  J. Pathol.  Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol; 197: 188–193 , 2002 .

[33]  D. Ruiter,et al.  Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group , 2002, The Journal of pathology.

[34]  C. Shea,et al.  Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. , 2002, Archives of dermatology.

[35]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[36]  M. Ross,et al.  Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. , 2001, Surgery.

[37]  S. Steinberg,et al.  Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Jonathan J. Lewis,et al.  Sentinel Lymph Node Biopsy in the Management of Patients With Primary Cutaneous Melanoma: Review of a Large Single-Institutional Experience With an Emphasis on Recurrence , 2001, Annals of surgery.

[39]  J. J. Coleman,et al.  Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma , 2000, Cancer.

[40]  Jeffrey E. Lee,et al.  Significance of Multiple Nodal Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy , 2000, Annals of Surgical Oncology.

[41]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[42]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Leong,et al.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. , 1998, Archives of dermatology.

[44]  M. Ross,et al.  Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. , 1998, Surgery.

[45]  D. Reintgen,et al.  Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk , 1988, Annals of surgery.

[46]  M. S. Blois,et al.  Regression in malignant melanoma. A histologic feature without independent prognostic significance , 1985, Cancer.

[47]  J. Kirkwood,et al.  Vitiligo in patients with metastatic melanoma: a good prognostic sign. , 1983, Journal of the American Academy of Dermatology.

[48]  A. Kopf,et al.  Regression in malignant melanoma. , 1983, Journal of the American Academy of Dermatology.

[49]  M. S. Blois,et al.  The regressing thin malignant melanoma. A distinctive lesion with metastatic potential , 1978, Cancer.

[50]  H. Schenker,et al.  Melanoma of the skin in a cow. , 1960 .